A Randomized Trial to Assess Functional and Structural Effects of Ranibizumab versus Laser in Diabetic Macular Edema (the LUCIDATE Study)-Reference-Cited by-同舟云学术

A Randomized Trial to Assess Functional and Structural Effects of Ranibizumab versus Laser in Diabetic Macular Edema (the LUCIDATE Study)

Published:2014-05 Issue:5 Volume:157 Page:960-970.e2
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Comyn Oliver,Sivaprasad Sobha,Peto Tunde^ORCID,Neveu Magella M.,Holder Graham E.,Xing Wen,Bunce Catey V.,Patel Praveen J.,Egan Catherine A.,Bainbridge James W.,Hykin Philip G.

Funder

Novartis

Allergan

Topcon United Kingdom

Bayer

Department of Health's National Institute for Health Research Biomedical Research Centre for Ophthalmology

National Institute for Health

Publisher

Elsevier BV

Subject

Ophthalmology

Reference22 articles.

1. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes;Klein;Ophthalmology,2009

2. Leading causes of certification for blindness and partial sight in England & Wales;Bunce;BMC Public Health,2006

3. The RESTORE Study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema;Mitchell;Ophthalmology,2011

4. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE;Nguyen;Ophthalmology,2012

5. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema;Elman;Ophthalmology,2010

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An ensemble deep learning model for OCT Image Detection and Classification;2024-09-12

2. The Natural History of Retinal Sensitivity Loss in Diabetic Macular Ischemia over One Year Evaluated by Microperimetry;Journal of Clinical Medicine;2024-04-11

3. Sustained Disease Control in DME Patients upon Treatment Cessation with Brolucizumab;Journal of Clinical Medicine;2024-03-07

4. Enhanced durability and evolution of retreatment criteria of intravitreal antivascular endothelial growth factor agents for diabetic macular edema;Current Opinion in Ophthalmology;2024-02-12

5. Progress in the Treatment of DME;Journal of Biosciences and Medicines;2024